Adam Havey, EVP, Biodefense Divison at Emergent BioSolutions Inc. (EBS), sold 12,337 shares at $27.50 ($339K) on 2014-03-12, disclosed to the SEC on 2014-03-13.
Seasonal sale ($339k) by EVP, Biodefense Divison — this insider has traded EBS in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.15 | 775 | $21K | 6.2% |
| 2 | $27.50 | 11,562 | $318K | 93.8% |
| Total | $27.48 avg | 12,337 | $339K | 100% |
| Filing → |
| EBS | SELL | 2020-04-08 | $478K | — | Filing → |
| EBS | SELL | 2019-03-13 | $277K | — | Filing → |
| EBS | SELL | 2019-03-04 | $354K | — | Filing → |